Serum Creatinine May Indicate Risk of Symptomatic Intracranial Hemorrhage After Intravenous Tissue Plasminogen Activator (IV tPA)
Symptomatic intracranial hemorrhage (sICH) is a known complication following administration of intravenous tissue plasminogen activator (IV tPA) for acute ischemic stroke. sICH results in high rates of death or long-term disability. Our ability to predict its occurrence is important in clinical deci...
Main Authors: | Marsh, Elisabeth B., Gottesman, Rebecca F., Hillis, Argye E., Urrutia, Victor C., Llinas, Rafael H. |
---|---|
Format: | Online |
Language: | English |
Published: |
Wolters Kluwer Health
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442012/ |
Similar Items
-
Intravenous tPA Therapy Does Not Worsen Acute Intracerebral Hemorrhage in Mice
by: Foerch, Christian, et al.
Published: (2013) -
Impacts of tissue-type plasminogen activator (tPA) on neuronal survival
by: Chevilley, Arnaud, et al.
Published: (2015) -
Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
by: Chapman, Sherita N, et al.
Published: (2014) -
Tissue plasminogen activator (tPA) in the management of predominantly hemorrhagic age-related macular degeneration, milligram/milliliter or microgram/milliliter?
by: Boone, Niels Willem, et al.
Published: (2012) -
Critical Care Needs in Patients with Diffusion-Weighted Imaging Negative MRI after tPA - Does One Size Fit All?
by: Faigle, Roland, et al.
Published: (2015)